​

Dianthus Therapeutics Ownership | Who Owns Dianthus Therapeutics?

OverviewForecastRevenueFinancialsChart

Dianthus Therapeutics Ownership Summary

Dianthus Therapeutics is owned by 7.53% institutional investors, 3.36% insiders, and 89.11% retail investors. Fmr is the largest institutional shareholder, holding 16.67% of DNTH shares.

DNTH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDianthus Therapeutics7.53%3.36%89.11%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr5.97M16.67%$234.94M
Fairmount funds management3.31M9.23%$130.14M
Avidity partners management lp3.20M8.94%$126.08M
Ra capital management2.87M8.00%$112.81M
Wellington management group llp2.58M7.20%$101.43M
Octagon capital advisors lp2.42M6.75%$95.10M
Point72 asset management2.04M5.70%$80.35M
Vanguard group2.05M5.42%$84.42M
Blackrock funding, inc. /de1.92M5.07%$78.93M
Tcg crossover management1.68M4.68%$65.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Avidity partners management lp3.20M28.70%$126.08M
Octagon capital advisors lp2.42M14.41%$95.10M
Fairmount funds management3.31M11.71%$130.14M
Sio capital management577.75K5.75%$22.73M
5am venture management365.05K5.26%$14.36M
Catalio capital management, lp667.62K4.86%$26.27M
Great point partners265.80K4.31%$10.46M
Silverarc capital management750.14K4.29%$30.91M
Bain capital life sciences investors1.32M3.44%$51.78M
Tcg crossover management1.68M3.25%$65.98M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp2.58M0.02%2.50M
Avidity partners management lp3.20M28.70%1.46M
Fmr5.97M0.01%1.43M
Braidwell lp835.06K0.97%835.06K
Polar capital748.00K0.14%748.00K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---2.23M
Vestal point capital, lp1.18M2.10%-2.02M
Bain capital life sciences investors1.32M3.44%-1.17M
Janus henderson group---683.62K
Rtw investments, lp---666.67K

New Positions

HolderShares% AssetsChangeValue
Polar capital748.00K0.14%748.00K$29.43M
Marshall wace, llp572.94K0.02%572.94K$22.55M
Vivo capital354.00K1.12%354.00K$13.93M
Ikarian capital346.00K1.37%346.00K$13.62M
Affinity asset advisors262.10K0.90%262.10K$10.31M

Sold Out

HolderChange
Montag a & associates-9.00
Creative financial designs inc /adv-10.00
Principal securities-11.00
Corecap advisors-11.00
Td private client wealth-17.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202522-85.23%2,846,620-93.92%70.04%15-84.38%6-82.35%
Sep 30, 202534-67.31%2,900,005-92.58%80.07%22-54.17%7-82.05%
Jun 30, 20251041.96%39,106,7373.69%1090.90%48-3934.48%
Mar 31, 202512-87.23%14,988,897-56.30%430.44%5-90.74%3-86.36%
Dec 31, 2024964.35%35,129,79412.00%1021.22%55-2315.00%

Recent Insider Transactions

DateNameRoleActivityValue
Dec 04, 2025Savitz Ryan CFO & CBOSell$903.60K
Nov 13, 2025Randhawa Simrat EVP, Head of R&DSell$1.58M
Nov 14, 2025Randhawa Simrat EVP, Head of R&DSell$4.16M
Nov 13, 2025Randhawa Simrat EVP, Head of R&DSell$700.69K
Nov 13, 2025Randhawa Simrat EVP, Head of R&DSell$936.74K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4-5
2025 Q3-1
2025 Q2--
2025 Q1--

DNTH Ownership FAQ

Who Owns Dianthus Therapeutics?

Dianthus Therapeutics shareholders are primarily institutional investors at 7.53%, followed by 3.36% insiders and 89.11% retail investors. The average institutional ownership in Dianthus Therapeutics's industry, Biotech Stocks , is 384.55%, which Dianthus Therapeutics falls below.

Who owns the most shares of Dianthus Therapeutics?

Dianthus Therapeutics’s largest shareholders are Fmr (5.97M shares, 16.67%), Fairmount funds management (3.31M shares, 9.23%), and Avidity partners management lp (3.2M shares, 8.94%). Together, they hold 34.84% of Dianthus Therapeutics’s total shares outstanding.

Does Blackrock own Dianthus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dianthus Therapeutics.

Who is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested?

Avidity partners management lp is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested, with 28.70% of its assets in 3.2M Dianthus Therapeutics shares, valued at 126.08M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools